跳至主要内容
临床试验/TCTR20190308003
TCTR20190308003招募中2 期

Appropriate protamine dosage for post cardiopulmonary bypass patient with borderline activated clotting time

Faculty of Medicine Ramathibodi hospital Mahidol University0 个研究点目标入组 140 人开始时间: 2019年3月8日最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
入组人数
140

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 80 Years(—)
性别
All

入选标准

  • 1.elective cardiac surgery patients using cardiopulmonary bypass
  • 2.no bleeding tendency preoperative (abnormal platelet, aPTT, PT, INR)
  • 3. no preoperative anticoagulant drugs

排除标准

  • 1.Suspected heparin resistance, heparin induced thrombocytopenia
  • 2.Hypothermia patient (Core temperature below 36 Celcius)
  • 3.Cardiopulmonary bypass time more than 2 hours
  • activated clotting time (ACT) value after 1st routine protamine dose below 120 seconds or more than 160 seconds or more than baseline value 15%
  • 4.Deny or request for exclude from study

研究者

相似试验